Drug Type Cell therapy |
Synonyms H3K27M-specific EIE therapy(Shenzhen Geno-Immune Medical Institute), H3K27M-specific engineered immune effector therapy(Shenzhen Geno-Immune Medical Institute) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diffuse Intrinsic Pontine Glioma | Phase 2 | China | 30 Jun 2027 | |
| Diffuse Midline Glioma | Phase 2 | China | 30 Jun 2027 |





